David Young

Processa Pharmaceuticals, Inc. (PCSA)

Head of Investor Relations

Aflac Inc (AFL)

CEO

Processa Pharmaceuticals, Inc. (PCSA)

Board Member

Processa Pharmaceuticals, Inc. (PCSA)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Processa Pharmaceuticals, Inc. (PCSA)
Board Member

Proxy statement

Current
2017-01-01–present
Processa Pharmaceuticals, Inc. (PCSA)
Proxy statement

Current
Aflac Inc (AFL)
Head of Investor Relations

Source not stated

Current
Processa Pharmaceuticals, Inc. (PCSA)
CEO

Proxy statement

Current

Company network

Recorded roles and earnings-call appearances connecting this person to public companies.

AFL

Current role

Head of Investor Relations

9 calls Latest call 2026-08-06

View earnings calls

Processa Pharmaceuticals, Inc.

PCSA

Current role

CEO, Board Member

2017-01-01–present

8 calls Latest call 2023-03-31

View earnings calls

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Processa Pharmaceuticals, Inc. (PCSA)	President, Research and Development and former Chief Executive Officer	$290,940	—	$14,484	—	—	—	$305,424
2023	Processa Pharmaceuticals, Inc. (PCSA)	President, Research and Development and former Chief Executive Officer	$160,200	—	$26,433	—	—	—	$186,633
2022	Processa Pharmaceuticals, Inc. (PCSA)	President, Research and Development and former Chief Executive Officer	$93,875	—	$1,068,744	—	—	—	$1,162,619
2021	Processa Pharmaceuticals, Inc. (PCSA)	Chief Executive Officer	$87,500	—	$347,012	—	—	—	$434,512
2020	Processa Pharmaceuticals, Inc. (PCSA)	Chief Executive Officer	$58,333	—	$380,052	—	—	—	$438,385
2019	Processa Pharmaceuticals, Inc. (PCSA)	Chief Executive Officer	—	—	—	$163,202	—	—	$163,202

Recent activity

Earnings-call appearances and filed executive appointments or departures, newest first.

Earnings call Second quarter teleconference (webcast event) Aflac Inc (AFL)
2026-08-06
Earnings call Aflac Inc Q1 FY2026 Earnings Call Aflac Inc (AFL)
2026-04-29
Earnings call Aflac Inc Q4 FY2025 Earnings Call Aflac Inc (AFL)
2026-02-04
Earnings call Aflac Inc Q2 FY2025 Earnings Call Aflac Inc (AFL)
2025-08-05
Earnings call Aflac Inc Q2 FY2023 Earnings Call Aflac Inc (AFL)
2023-08-01
Earnings call Processa Pharmaceuticals, Inc. Q4 FY2022 Earnings Call Processa Pharmaceuticals, Inc. (PCSA)
2023-03-31
Earnings call Aflac Inc Q4 FY2022 Earnings Call Aflac Inc (AFL)
2023-02-01
Earnings call Processa Pharmaceuticals, Inc. Q3 FY2022 Earnings Call Processa Pharmaceuticals, Inc. (PCSA)
2022-11-08
Earnings call Processa Pharmaceuticals, Inc. Q2 FY2022 Earnings Call Processa Pharmaceuticals, Inc. (PCSA)
2022-08-12
Earnings call Processa Pharmaceuticals, Inc. Q1 FY2022 Earnings Call Processa Pharmaceuticals, Inc. (PCSA)
2022-03-31
Earnings call Aflac Inc Q4 FY2021 Earnings Call Aflac Inc (AFL)
2022-02-02
Earnings call Processa Pharmaceuticals, Inc. Q4 FY2021 Earnings Call Processa Pharmaceuticals, Inc. (PCSA)
2021-12-31

Show 5 earlier activities

Earnings call Processa Pharmaceuticals, Inc. Q3 FY2021 Earnings Call Processa Pharmaceuticals, Inc. (PCSA)
2021-09-30
Earnings call Processa Pharmaceuticals, Inc. Q2 FY2021 Earnings Call Processa Pharmaceuticals, Inc. (PCSA)
2021-08-13
Earnings call Processa Pharmaceuticals, Inc. Q1 FY2021 Earnings Call Processa Pharmaceuticals, Inc. (PCSA)
2021-05-13
Earnings call Aflac Inc Q1 FY2021 Earnings Call Aflac Inc (AFL)
2021-04-28
Earnings call Aflac Inc Q3 FY2020 Earnings Call Aflac Inc (AFL)
2020-10-27